期刊文献+

基于逆转录病毒载体的外源基因表达系统的评价和应用 被引量:4

Evaluation and application of exogenous gene expression system based on retroviral vector
原文传递
导出
摘要 逆转录病毒表达系统是基因治疗研究和RNA干扰技术广泛采用的外源基因表达系统。文中以增强型绿色荧光蛋白(EGFP)基因的表达水平和稳定性为指标,比较逆转录病毒表达载体pQCXIN和pcDNA3.1(+)表达质粒介导的外源基因在HEK293细胞和CHO-K1细胞的表达效率。病毒感染HEK293细胞和CHO-K1细胞的相对荧光强度(Relative fluorescence intensity,RFI)均约为对应的质粒转染细胞的2倍。多轮反复感染逆转录病毒表达载体能有效提高HEK293细胞表达EGFP的效率。HEK293细胞经4轮病毒感染后的RFI值较1次病毒感染的RFI值约提高2倍。此外,逆转录病毒表达载体介导的外源基因表达的稳定性优于质粒转染的外源基因表达。采用携带人重组活性蛋白C(Recombinant human activated protein C,rhAPC)基因的pQCXIN和HEK293细胞进一步验证了逆转录病毒载体介导的外源基因表达效率,构建了rhAPC表达水平为10~15μg/(106 cells.d)的HEK293细胞系。研究结果表明,逆转录病毒表达系统是有应用价值的介导外源基因在哺乳动物细胞高效表达的技术途径。 Currently,exogenous gene expression system based on retroviral vector has been widely used as efficient gene expression system in both gene therapeutic research and RNA interference.In this study,we evaluated the efficiency of exogenous gene expression mediated by the retroviral vector in mammalian cells.First,we constructed EGFP(enhanced green fluorescent protein) vector using pcDNA3.1(+) and retroviral vector pQCXIN as backbone vector respectively.Then,we transfected or infected HEK293 cells and CHO-K1 cells with above vector or corresponding retroviral virus,and measured the relative fluorescence intensity(RFI) of EGFP.The results showed that the RFI of the retroviral virus-infected cells was two times higher than that of the plasmid-transfected cells.Further experiments revealed repeated virus infection enhanced the expression of EGFP markedly,with RFI increasing twice after four rounds of virus infection.Furthermore,the EGFP expression in HEK293 cells mediated by the retroviral vector was more stable than transfected with plasmid pcDNA3.1(+).Finally,we further validated the efficiency of exogenous gene expression system based on the retroviral vector by expressing recombinant human activated protein C(rhAPC) in HEK293 cells.We obtained HEK293 cell lines with rhAPC expression between 10 and 15 ?g/(106 cells?d).In conclusion,the exogenous gene expression system based on the retroviral vector is an alternative method for the generation of stable and high-expressing mammalian cell lines.
出处 《生物工程学报》 CAS CSCD 北大核心 2011年第8期1225-1231,共7页 Chinese Journal of Biotechnology
基金 "重大新药创制"科技重大专项(No.2009ZX09503-011)资助~~
关键词 逆转录病毒 载体 外源基因 表达 生物技术药物 retroviral vector exogenous gene expression biopharmaceuticals
  • 相关文献

参考文献14

  • 1Dingermann T. Recombinant therapeutic proteins: production platforms and challenges. Biotechnol J, 2008, 3(1): 90-97.
  • 2Dutton G. Trends in monoclonal antibody production. Gen Eng Biotechnol News, 2010, 30(4): 22-27.
  • 3Durocher Y, Butler M. Expression systems for therapeutic glycoprotein production. Curr Opin Biotechnol, 2009, 20(6): 700-707.
  • 4Strohl WR, Knight DM. Discovery and development of biopharmaceuticals: current issues. Curr Opin Biotechnol, 2009, 20(6): 668- 672.
  • 5Bushman F, Lewinski M, Ciuffi A, et al. Genome-wide analysis of retroviral DNA integration. Nat Rev Microbiol, 2005, 3(11): 848-858.
  • 6Daniel R, Smith JA. Integration site selection by retroviral vectors: molecular mechanism and clinical consequences. Hum Gene Ther, 2008, 19(6): 557-568.
  • 7McTaggart S, A1-Rubeai M. Retroviral vectors for human gene delivery. Biotechnol Adv, 2002, 20(1) 1-31.
  • 8Storvold GL, Gjernes E, Askautrud HA, et al. A retroviral vector for siRNA expression in mammalian cells. Mol Biotechnol, 2007, 35(3): 275-282.
  • 9Low R. The use of retroviral vectors for tet-regulated gene expression in cell populations. Methods Mol Biol, 2009, 506: 221-242.
  • 10Bleck GT. An alternative method for the rapid generation of stable, high-expressing mammalian cell lines. Bioproc J, 2005, 4: 43-51.

同被引文献51

  • 1BUSHMAN F D. Retroviral integration and human gene therapy [ J ]. J Clin Invest, 2007, 117 (8) : 2083-2086.
  • 2TAKAHASHI K, YAMANAKA S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cul- tures by defined factors [ J ]. Cell, 2006, 126 (4) : 663- 676.
  • 3MILLER A D, ROSMAN G J. Improved retroviral vectors for gene transfer and expression [ J ]. Biotechniques, 1989, 7(9) : 980-990.
  • 4BURNS J C, FRIEDMANN T, DRIEVER W, et al. Ve- sicular stomatitis virus G glycoprotein pseudotyped retrovi-ral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells [J]. Proc Natl Acad Sci USA, 1993, 90(17): 8033- 8037.
  • 5ANNENKOV A E, DALY G M, CHERNAJOVSKY Y. Highly efficient gene transfer into antigen-specific primary mouse lymphocytes with replication-deficient retrovirus ex- pressing the 10A1 envelope protein [ J]. J Gene Med, 2002, 4(2) : 133-140.
  • 6KITAMURA T, KOSHINO Y, SHIBATA F, et al. Retro- virus-mediated gene transfer and expression cloning: Pow- erful tools in functional genomics [ J ]. Exp Hematol, 2003, 31(11) : 1007-1014. with buffalo defined factors [J. Stem Cells Dev, 2012, 21(13): 2485-2494.
  • 7MILLER A D, CHEN F. Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry [ J ]. J Virol, 1996, 70(8) : 5564-5571.
  • 8DENG Yanfei, LIU Qingyou, LUO Chan, et al. Genera- tion of induced pluripotent stem ceils from buffalo ( Buba- lus bubalis ) fetal fibroblasts.
  • 9Forman D,de Martel C,Lacey CJ,et al. Global burden of human papillomavirus and related diseases [J]. Vaccine, 2012,30(Suppl 5) : F12-F23.
  • 10Kamran MZ, Patil P, Gude RP. Role of STAT3 in cancer metastasis and translational advances [J]. Biomed Res Int, 2013,2013:421821. cervical carcinogenesis [J]. PLoS One, 2013,8(7 ) : e67849.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部